NQ301
CAS No. 130089-98-4
NQ301 ( NQ-301 | NQ 301 | NQ301 )
产品货号. M17241 CAS No. 130089-98-4
NQ301 是一种抗血栓剂,可抑制胶原蛋白挑战的兔血小板聚集(IC50:10 mg/mL)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥473 | 有现货 |
|
| 10MG | ¥710 | 有现货 |
|
| 25MG | ¥1163 | 有现货 |
|
| 50MG | ¥1795 | 有现货 |
|
| 100MG | ¥2592 | 有现货 |
|
| 500MG | ¥5922 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥521 | 有现货 |
|
生物学信息
-
产品名称NQ301
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NQ301 是一种抗血栓剂,可抑制胶原蛋白挑战的兔血小板聚集(IC50:10 mg/mL)。
-
产品描述NQ-301 is a Selective CD45 inhibitor with Antiplatelet and antithrombotic activities (IC50 = 200 nM). NQ301 inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. The antiplatelet activity of NQ301 may be mediated by inhibition of cytosolic Ca2+ mobilization, enhancement of cAMP production and inhibition of ATP secretion in activated platelets.
-
体外实验NQ301 concentration-dependently inhibits collagen (10 mg/mL)-, U46619 (1 mg/mL)- and arachidonic acid (100 mg/mL)-challenged rabbit platelet aggregation, with IC50values of 0.60±0.02, 0.58±0.04 and 0.78±0.04 μM, respectively. NQ301 potently suppresses thromboxane B2 formation by platelets that are exposed to arachidonic acid in a concentration-dependent manner, but had no effect on the production of prostaglandin D2, indicating an inhibitory effect on thromboxane A2 synthase. NQ301 has a potential to inhibit thromboxane A2 synthase activity with thromboxane A2/prostaglandin H2 receptor blockade, and modulate arachidonic acid liberation as well as 12-hydroxy-5,8,10,14-eicosatetraenoic acid formation in platelets. NQ301 inhibits platelet aggregation by suppression of the intracellular pathway, rather than by direct inhibition of fibrinogen-GPIIb/IIIa complex binding. NQ301 significantly inhibits the increase of cytosolic Ca2+ concentration and ATP secretion, and also significantly increases platelet cAMP levels in the activated platelets. The antiplatelet activity of NQ301 may be mediated by inhibition of cytosolic Ca2+ mobilization, enhancement of cAMP production and inhibition of ATP secretion in activated platelets.
-
体内实验——
-
同义词NQ-301 | NQ 301 | NQ301
-
通路Angiogenesis
-
靶点c-Met/HGFR
-
受体arachidonic acid-challenged rabbit platelet aggregation| collagen-challenged rabbit platelet aggregation| U46619-challenged rabbit platelet aggregation
-
研究领域Cardiovascular Disease|Infection
-
适应症——
化学信息
-
CAS Number130089-98-4
-
分子量325.75
-
分子式C18H12ClNO3
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 29 mg/mL. 89.03 mM
-
SMILESCC(=O)c1ccc(cc1)NC1=C(C(=O)c2ccccc2C1=O)Cl
-
化学全称2-[(4-Acetylphenyl)amino]-3-chloro-1,4-naphthalenedione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Jin YR, et al. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):162-7.
021-51111890
购物车()
sales@molnova.cn

